CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of ODM-104 Compared to a Standard Combination (Stalevo®); a Randomized Double-blind, Crossover Proof-of-concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02764125
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:57.718428+00:00
Published At: 2018-04-05T00:00:00+00:00
Record Updated At: 2018-04-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Parkinson\u0027s Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-04-05"
protocolSection.identificationModule.nctId: "NCT02764125"
protocolSection.identificationModule.officialTitle: "Efficacy and Safety of ODM-104 Compared to a Standard Combination (Stalevo\u00ae); a Randomized Double-blind, Crossover Proof-of-concept Study in Patients With Parkinson\u0027s Disease and End-of-dose Wearing-off"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.